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Abstract
Background: Antipsychotic medications (APMs) are commonly prescribed in nursing homes (NHs) and their excessive
use raises concerns about the quality of care. They are often seen as “chemical restraints”, and were shown to increase
morbidity and mortality risks in NH residents. The objective of this study was to investigate the variability in prevalence
in APM use in a sample of Israeli NHs and to examine the effect of facility characteristics on the use of APMs.
Methods: A retrospective cross-sectional study was conducted in 2011 using data which were collected in a sample of
NHs in the Tel Aviv district during the annual certification process. Prevalence of APMs was determined on the basis of
all residents using antipsychotics on a regular basis. The association between facility characteristics and APM use was
assessed by multivariate analysis.
Results: Forty-four NHs providing care for 2372 residents were investigated. The prevalence of APM use varied
between facilities from 14.8 to 70.6 %, with an overall prevalence of 37.3 %. Multiple linear regression analysis
revealed that greater use of APMs was associated with for-profit facilities, facilities in which most of the residents
were self-pay, the presence of a “mentally frail” unit, a medical director non-specialized in geriatrics, shortage of
social workers and occupational therapists, presence of unsafe/non-fitting equipment or self-aids (e.g., unsafe
bath/toilet seats, unsuitable height of tables) and shortage of recreational activities.
Conclusions: A wide variation in APM use was recorded in NHs in the Tel Aviv district. This variation was associated
with facility characteristics that undermine quality of care. Application of APM use as a measure of quality in NHs and
publicizing their utilization may decrease their overall use.
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Background
The widespread use of antipsychotic medications (APMs)
in nursing homes (NHs) has been a matter of concern for
many years [1]. APMs are often seen as “chemical re-
straints”, and they have been shown to increase morbidity
and mortality risks in NH residents [2]. Newer atypical
antipsychotic therapies (e.g., risperidone, quetiapine,
olanzapine) were introduced in the 1990s, and they were
thought to be safer than the early conventional anti-
psychotic therapy (e.g., haloperidol, zuclopenthixol, per-
phenazine, thioridazine). However, evidence subsequently
showed that the use of atypical agents was associated with
serious adverse events, including falls, abnormal gait,
stroke and even death [3]. Despite uncertainties about the
benefits and risks of APMs in the elderly, their prevalence
remains high in NHs. A recent study reported an overall
32.8 % prevalence of APMs use in a voluntary sample of
NH residents with dementia in 7 European countries and
Israel. APM use differed by country, ranging from 60 % in
10 NHs in the Czech Republic to 18 % in 7 NHs in Israel
[4]. Additionally, US data indicated that nearly one-third
of elderly NH residents with dementia received APMs,
mainly atypical agents [5].
The licensed indications for APMs in Israel are based
on their FDA approval which was received for demon-
strated efficacy in schizophrenia, psychotic disorders and,
* Correspondence: shai_f@zahav.net.il
1Braun School of Public Health and Community Medicine, Hebrew
University-Hadassah, Jerusalem, Israel
Full list of author information is available at the end of the article
© 2016 Frankenthal et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Frankenthal et al. Israel Journal of Health Policy Research  (2016) 5:12 
DOI 10.1186/s13584-016-0070-y
more recently, for bipolar disorder and unresolved severe
depression. Although generally not approved for this use,
APMs are prescribed in NHs mainly for off-label indica-
tions e.g., to manage dementia associated behavioral dis-
turbances [6]. Specifically, behavioral symptoms include
aggression, wandering and screaming, and they constitute
a major cause of staff distress [7]. The potential misuse of
APMs is an ongoing quality concern in NHs, particularly
because these medications simply sedate residents who
exhibit disturbing behaviors or resist care [2]. The
boredom and isolation that result from inactivity and the
monotony of the NH environment may lead to many of
the behavioral symptoms exhibited by people with
dementia [7]. Furthermore, needs such as those pertaining
to relief of discomfort and pain have also been shown to
be associated with difficult behaviors [8].
Some studies have suggested that there was an institu-
tional “culture” for prescribing APMs. One study showed
that residents entering NHs with the highest facility-
level antipsychotic rates were 1.37 times more likely to
receive APMs compared to those entering the lowest
prescribing rate NHs [9]. Another study found that
residents in facilities with high APM prescribing rates
were about 3 times more likely to be prescribed them
than residents in facilities with low prescribing rates, ir-
respective of their clinical indications [3]. Given the ser-
ious events associated with the use of antipsychotic
therapy, it is important to explore the relationship be-
tween the NH environment and the prescription of
APMs.
The aim of this study was to investigate the variability
in prevalence in APM use in a sample of Israeli NHs




This retrospective cross-sectional study used two
merged data sources. One is the computerized geriatric
department data system (AGAM), which provides facil-
ity level information for all certified NHs in Israel. A
multidisciplinary team of national inspectors, which is
comprised of experts from the fields of medicine, nurs-
ing, physiotherapy, occupational therapy, nutrition and
pharmacology, routinely collects data on each geriatric
facility as part of the annual certification process. They
retrieve data, which include structure and process indi-
cators, on descriptive characteristics (i.e., ownership, oc-
cupancy), levels of the staff members (i.e., qualifications,
expertise), and they evaluate multidisciplinary working
procedures in order to measure the quality of care in the
facility. The other source involves the prescribing of
APMs (an outcome indicator), which was assessed only
during 2011 by the study pharmacist in a sample of NH
residents in the Tel Aviv district during the annual certi-
fication process. The Ministry of Health supervises the
prolonged hospitalization for the nursing and mentally
frail elderly. NHs comprise different types of wards and
residents are stratified by their level of disability. Data
were collected for residents with and without cognitive
impairment who were dependent in carrying out their
activities of daily living (nursing wards), and for resi-
dents who were primarily cognitively impaired but were
able to walk independently (mentally frail units).
Study sample
The Tel Aviv district is composed of 10 cities which are
located in central Israel. Forty-four of the 60 geriatric
facilities within the district were randomly selected
(about one facility a week) for assessment of APM pre-
scribing policies in 2011. We used the data which were
collected in those facilities for this study. The study
protocol was reviewed and approved by the E. Wolfson
Hospital’s institutional ethical review board which
waived informed consent.
Prescribing protocol
APMs are prescribed by physicians employed in NHs. The
prevalence of APMs was determined on the basis of all
residents ingesting them on a regular basis on the day of
the inspection. Residents were classified as not taking any
APMs, taking one APM (either a conventional or an
atypical agent) or taking more than one APM.
Facility characteristics
The selected facility predictors that were likely to have an
impact on APM use included: ownership (profit or non-
profit), source of payment by residents (most of the
residents in the facility were self-pay or not self-pay [the
latter payment to the facility being subsidized by the
Ministry of Health]), number of beds, shortage of staff
members (fewer working hours per month for each discip-
line than the professional standard set by the Ministry of
Health), specialization of the medical director (geriatri-
cian/non-geriatrician), the presence of a “mentally frail”
unit (not all NHs have these units and they can be present
in profit or non-profit facilities), the existence of diversi-
fied and adequate recreational activities (a variety of
activities existed and activities were carried out daily),
treatment by an occupational therapist (treatment was
categorized into “absent”, “partial” and “available” while
“absent” was defined as no treatment due to the lack of an
occupational therapist and “available” was defined as the
availability of treatment to all residents who need it),
pain assessment (pain being measured at least once
weekly among all residents), suitable outdoor environ-
ment (i.e., enough space for strolling, access to a garden
or open area), safe and well-fitting self-aid equipment
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(e.g., safe bath/toilet seats, height of tables fitted to
residents’ needs) and the use of minimum physical
restraints (a prevalence of ≤10 % of patients on the day
of inspection).
The selected facility characteristics for the present
study were measured by the multidisciplinary team of
national inspectors during the annual certification
process, each one in his/her field of expertise and were
derived for this study as yes/no present/absent replies.
Statistical analysis
Statistical analysis was performed using the Statistical
Package of Social Sciences (SPSS) version 14.0 (Chicago,
IL, USA). Multivariate analysis using a backward linear re-
gression was applied to examine the association between
independent risk factors and the use of APMs. The follow-
ing variables were entered in the linear regression model:
facility characteristics (number of beds, profit/non-profit
facilities, most of the residents in the facility were self-pay/
not self-pay patients), specialization of the medical dir-
ector (geriatrician/non-geriatrician), shortage of medical
staff (physicians, nurses, occupational therapists, physio-
therapists, dieticians and social workers), presence of a
“mentally frail” unit, recreational activities, safe and well-
fitting environment/equipment, pain assessment, treat-
ment by an occupational therapist and minimum use of
physical restraints. Significance was set at P < 0.05.
Results
Characteristics of the geriatric facilities
A total of 44 geriatric facilities had been randomly se-
lected for inspection during the annual certification
process from January 1, 2011 to January 1, 2012. Table 1
provides a descriptive overview of the 44 facilities (2372
residents) included in the analysis. Most (65.9 %) of
them were for profit, and the medical director was spe-
cialized in geriatrics in 17 (38.6 %). The most prominent
shortage of medical staff was that of occupational thera-
pists (59.1 %), followed by a shortage of dieticians
(43.2 %) and nurses (38.6 %). Data on the quality of rec-
reational activities in the facility showed that it was nei-
ther diversified nor adequate in 21 (47.7 %) facilities.
The physical environment was not adequate (not enough
space for strolling or no access to a garden or open
space) in 15 (34.1 %) facilities, and the equipment used
by residents was not safe/well-fitting in 19 (43.2 %).
Variation in the use of antipsychotic therapy
The prevalence of APM use varied between facilities from
14.8 to 70.6 %, with an overall prevalence of 37.3 %. Of all
the residents who were prescribed an APM, an average of
90.6 % received only one APM and an average of 58.15 %
were prescribed atypical APMs. Risperidone was the most
common atypical APM (30.7 %), followed by quetiapine
(16.7 %) and olanzapine (5.4 %).
Multiple linear regression analysis (Table 2) re-
vealed that there was more prescribing of APMs in
for-profit facilities (β = −0.37, P = 0.008), when the
medical director of the facility was not a geriatrician
(β = 0.46, P = 0.001), when there was a “mentally frail”
unit (β = 0.47, P = 0.001), when most of the residents
were self-pay (β = -0.64, P = 0.001), and when there
were shortages of social workers (β = 0.31, P = 0.019),
occupational therapists (β = 0.33, P = 0.017), safe/well-
fitting equipment (β = 0.31, P = 0.037), and recre-
ational activities (β = 0.32, P = 0.018). The number of
nursing beds, the shortage of physicians, nurses,
dieticians and physiotherapists, the use of physical
restraint, treatment by an occupational therapist,
provision of a suitable environment and routine
measurement of pain were not predictors for the pre-
scription of APMs.
Table 1 Characteristics of the facilities (N = 44)
Facility characteristics No of facilities %
Number of nursing beds in the facility
<60 27 (61.4 %)
60–150 14 (31.8 %)
>150 3 (6.8 %)
Medical director has specialization in geriatrics 17 (38.6 %)
Shortage in personnel
Physician 7 (15.9 %)
Nurse (with and without an academic degree) 17 (38.6 %)
Social Worker 8 (18.2 %)
Physiotherapist 9 (20.5 %)
Occupational Therapist 26 (59.1 %)
Dietician 19 (43.2 %)
For-profit facility 29 (65.9 %)
Facilities in which most of the residents are
self-pay patients
22 (50 %)
Has a "mentally frail" unit 8 (18.2 %)
Non-suitable environment (i.e., not enough space
for strolling, no access to a garden or open area)
15 (34.1 %)
Unsafe/non-fitting self-aid equipment (e.g., unsafe
bath/toilet seats, unsuitable height of tables)
19 (43.2 %)
Recreational activities are not diversified and
not adequate
21 (47.7 %)
Treatment by occupational therapist
Absent 11 (25 %)
Partial 22 (50 %)
Available 11 (25 %)
Use of minimum physical restraint (≤10 % of patients) 17 (38.6 %)
Pain is not routinely measured among all residents 19 (43.2 %)
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Discussion
The findings of the current study demonstrate that the
use of antipsychotic therapy varies considerably across
NHs in the Tel Aviv district, and that this variability is
associated with facility characteristics. The prevalence of
APM use ranged between facilities from 14.7 to 70.6 %,
with an overall of 37.3 % and is comparable with results
from other studies [1, 3–5, 10, 11]. Hughes et al.
reported a wide variability (ranging from 0 to 75 %) in
the use of APMs in 14,631 US long-term care facilities
[12]. Those authors showed that facility and resident
characteristics were associated with the use of APMs,
although the extent to which these factors explained this
variability differed according to the financial incentives
of the facility (for-profit, nonprofit or government) [12].
Another study carried out one decade later on a random
sample of 1257 US NHs reported that facility-level APM
prescribing rates ranged from 0 to 100 % [9]. That study
showed that patients diagnosed with schizophrenia,
bipolar disorder or aggressive behavioral symptoms of
dementia accounted for only a small proportion of APM
use, and the authors concluded that a prescribing
culture exists in NHs. These findings demonstrate the
persistent variability of APMs in NHs in the US which
have not changed appreciably since first reported in
2000. In The Netherlands, a wide variation in APM use
was demonstrated in a voluntary sample of 20 long-term
care facilities ranging from 5 to 52 %, with an overall
prevalence of 31 % [1]. That study showed that facilities
with a high prevalence of APM use were often large,
situated in urban communities and scored below average
on staffing, personal care and recreational activities [1].
In Ontario, Canada, antipsychotic prescribing in 485
provincially regulated NHs ranged from 20.9 to 44.3 %
[3]. The variation in APM use in Canada was not ad-
equately accounted for by measured differences in the
characteristics of the residents, and it was concluded
that antipsychotic therapy was not based on clinical indi-
cations but rather on the NH environment, with some
environments being more permissive than others about
APM use [3]. The authors did not determine what it was
about the NH that influenced prescribing.
The variability in APM use in the surveyed Israeli NHs
was associated with facility characteristics. The present
study demonstrated an association between non-profit
facilities and lower prevalence of antipsychotic use. This is
consistent with the findings in other studies, and it reflects
the underlying assumption that higher-quality care may
be a more important goal than maximizing profit in non-
profit facilities [12–14]. Aaronson et al. [15] observed that
non-profit facilities provided significantly higher quality of
care to residents compared with for-profit NHs, as
demonstrated by better health outcomes among residents
with higher risk for adverse outcomes. Furthermore,
Hughes et al. [12] reported an inappropriate use of APMs
as chemical restraints in NH environments in which there
was more demand upon increasing profits.
The current study demonstrated that the source of pay-
ment was also associated with APM use. There was higher
APM use in facilities with more self-pay residents. The
Ministry of Health supervises all certified NHs regardless
of the payer source and non-self-pay residents can go
either to non-profit or for-profit facilities. The Ministry of
Health’s reimbursement to facilities for non-self-pay
residents may result in the delivery of better care to such
patients as reflected by lower APM use. We believe that
credit for this finding should go to the constant supervi-
sion by the Ministry of Health on the services supplied to
those residents. Further investigation into this assumption
is warranted.
Specialization in geriatrics by the medical director was
associated with a reduced use of APMs. The medical dir-
ector of a NH is in charge of the supervision of all medical
activity including prescribing decisions. Azerramai et al.
reported that APM use was significantly lower in NHs
where patients received treatment from a general practi-
tioner with additional training in gerontology [16]. These
findings support the likelihood that perceptions shared by
physicians working within a NH may be expressed as
facility-level preferences for certain therapeutic regimens
[9]. We suggest that a physician with a specialization in
geriatrics may promote non-pharmacological interven-
tions as first-line treatments for behavioral problems of
dementia before the initiation of APMs more than other
physicians.
Shortages of occupational therapists and social workers
were found to be associated with a greater use of APMs.






Medical director has no
specialization in geriatrics
11.74 0.46 3.86 0.001
Has a "mentally frail" unit 15.51 0.47 3.65 0.001
Most residents are self-pay −15.62 −0.64 −3.68 0.001
For-profit facility −9.80 −0.37 −2.83 0.008
Shortage of social workers 9.76 0.31 2.48 0.019
Shortage of occupational
therapists
8.29 0.33 2.52 0.017
aRecreational activities
are not diversified and
not adequate
18.60 0.32 2.49 0.018
bUnsafe/non-fitting
self-aid equipment
7.70 0.31 2.18 0.037
Sig significance
aRecreational activities were measured by an inspector who is an
occupational therapist
bAids were judged as being safe and well-fitting according to an inspector
who is a nurse
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The lack of sufficient and qualified staff was reported as a
barrier to the success of non-pharmacological interven-
tions, thereby increasing the demand for APMs [1, 17].
The use of medications as chemical restraints can serve as
substitutes for staff members. APM use was reportedly
less prevalent in facilities that were well run and where
staff levels were appropriate with resident needs [12].
As could be expected, more APMs were used in facil-
ities with a “mentally frail” unit. More of those residents
were diagnosed with dementia, and the prevalence of
behavioral problems associated with dementia was
higher in those facilities.
The level of recreational activity in a facility was also
associated with APM use. Kleijer et al. found a strong
association between low satisfaction with the provided
recreational activities and facility-level APM use [1]. The
use of recreational activity programs can improve the
residents’ quality of life by reducing the boredom and
isolation that may precipitate behavioral problems, and
thus decrease the demand for APM use [18, 19]. Most
agitated behaviors are manifestations of unmet needs
[8]. According to those authors, the most common of
those needs are for social and physical stimulation, both
of which are lacking because of the effects of dementia,
sensory deficits and the monotony of the NH environment
[8]. Recreational programs promote quality of life by
providing an appropriate level of stimulation by means of
meaningful activities [7].
Poorly fitting equipment, such as unadapted wheel-
chairs, dining/work tables or old non-fitting toilet/bath-
ing seats were associated with a greater use of APMs.
Environmental interventions which meet both the
comfort and the mobility needs of residents were sug-
gested for promoting the residents’ highest level of
functioning [8].
This study has several limitations. First, its cross-
sectional design precluded the determination of a causal
relationship between facility characteristics and the preva-
lence of APM use. Second, the 44 NHs are not necessarily
representative of all 300 NHs in Israel. Third, the study
did not use data on residents’ characteristics as indications
for the use of APMs. The strengths of this study are that
this is the first description of APM use in Israeli NHs and
that it provides some evidence of the impact of the NH
facility’s characteristics on APM use.
In summary, this study shows that a greater use of
APMs was associated with facility characteristics that gen-
erally indicate a lower quality of care. Shortage of staff, less
recreational activity, and flawed equipment and daily living
aids are all manifestations of poor quality of care. APMs
are prescribed as chemical restraints in lieu of sufficient
staff and appropriate activity for the residents of deficient
facilities. Prescribing an antipsychotic therapy to a resident
with no clinical indication for the therapy has been
identified by the Centers for Medicare and Medicaid
Services as a measure of poor quality of care [20].
In Israel, there are currently no formal guidelines on
monitoring the use of APMs and we hope that this study
will be instrumental in increasing the Ministry of Health’s
supervision of the prescription of APMs nationwide. We
believe that the inclusion of binding regulations on the
prescription of APMs in addition to the development of
skills for the care providers in non-pharmacological treat-
ment of behavioral disorders will decrease APM use [21].
Recent data showed that the publication of the prevalence
of APM use in NHs led to a remarkable decrease in the
use of APMs elsewhere [1, 11, 22]. We therefore believe
that making APM utilization data publically available in
Israel will decrease the overall use of APMs in NHs.
Conclusions
The wide variation in APM use that was found in NHs in
the Tel Aviv district was associated with facility character-
istics that undermine quality of care. The use of APMs as
a measure of quality of care in Israeli NHs would probably
lead to a decrease in their use and lower morbidity and
mortality risks in NH residents.
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